number,query,question,narrative,qe_wide_search,qe_refine_search
1,coronavirus origin,what is the origin of COVID-19,"seeking range of information about the SARS-CoV-2 virus's origin, including its evolution, animal source, and first transmission into humans","SARS-CoV-2 coronavirus origin zoonosis bat reservoir pangolin intermediate host phylogenetic MERS-CoV Betacoronavirus evolution","SARS-CoV-2 origin zoonotic spillover phylogenetic analysis pangolin reservoir evolutionary host adaptation recombination"
2,coronavirus response to weather changes,how does the coronavirus respond to changes in the weather,"seeking range of information about the SARS-CoV-2 virus viability in different weather/climate conditions as well as information related to transmission of the virus in different climate conditions","SARS-CoV-2 climate weather temperature humidity seasonality transmission stability viability Betacoronavirus environmental factors","SARS-CoV-2 temperature humidity seasonality environmental factors viral persistence epidemiology climate effect"
3,coronavirus immunity,will SARS-CoV2 infected people develop immunity? Is cross protection possible?,"seeking studies of immunity developed due to infection with SARS-CoV2 or cross protection gained due to infection with other coronavirus types","SARS-CoV-2 immunity immune response neutralizing antibodies T-cell cross-protection reinfection MERS-CoV immunological memory","SARS-CoV-2 immune response neutralizing antibodies T-cell cross-reactivity memory protective immunity cross-protection"
4,how do people die from the coronavirus,what causes death from Covid-19?,"Studies looking at mechanisms of death from Covid-19.","COVID-19 mortality fatal outcomes pathophysiology ARDS cytokine storm multiorgan failure pneumonia complications respiratory failure","COVID-19 fatal outcomes ARDS cytokine storm organ failure mortality risk factors disease severity pathophysiology"
5,animal models of COVID-19,what drugs have been active against SARS-CoV or SARS-CoV-2 in animal studies?,"Papers that describe the results  of testing drugs that bind to spike proteins of the virus or any other drugs in any animal models. Papers about SARS-CoV-2 infection in cell culture assays are also relevant.","SARS-CoV-2 animal models coronavirus preclinical studies antiviral drugs spike protein cell culture in vivo MERS-CoV drug testing","SARS-CoV-2 animal models preclinical antiviral efficacy spike protein binding drug testing in vivo cell culture"
6,coronavirus test rapid testing,what types of rapid testing for Covid-19 have been developed?,"Looking for studies identifying ways to diagnose Covid-19 more rapidly.","SARS-CoV-2 rapid test diagnostic assays point-of-care RT-PCR antigen test LAMP detection sensitivity specificity","SARS-CoV-2 rapid diagnostics point-of-care RT-PCR antigen detection LAMP sensitivity specificity"
7,serological tests for coronavirus,are there serological tests that detect antibodies to coronavirus?,"Looking for assays that measure immune response to COVID-19 that will help determine past infection and subsequent possible immunity.","SARS-CoV-2 serological assays antibody detection ELISA immunoglobulin IgM IgG neutralizing antibodies seroconversion sensitivity specificity","SARS-CoV-2 serological tests ELISA immunoglobulin IgM IgG neutralizing antibodies seroconversion specificity reliability"
8,coronavirus under reporting,how has lack of testing availability led to underreporting of true incidence of Covid-19?,"Looking for studies answering questions of impact of lack of complete testing for Covid-19 on incidence and prevalence of Covid-19.","COVID-19 underreporting testing gaps surveillance bias incidence prevalence asymptomatic carriers limited testing","COVID-19 underreporting incidence prevalence testing limitations asymptomatic detection incomplete surveillance case ascertainment"
9,coronavirus in Canada,how has COVID-19 affected Canada,"seeking data related to infections (confirm, suspected, and projected) and health outcomes (symptoms, hospitalization, intensive care, mortality)","COVID-19 Canada epidemiology incidence prevalence mortality hospitalization ICU outcomes public health measures","COVID-19 Canada epidemiology hospitalization ICU mortality regional outbreak public health strategies"
10,coronavirus social distancing impact,has social distancing had an impact on slowing the spread of COVID-19?,"seeking specific information on studies that have measured COVID-19's transmission in one or more social distancing (or non-social distancing) approaches","COVID-19 social distancing transmission reduction R0 physical distancing mitigation pandemic containment community spread modeling","COVID-19 social distancing transmission control R0 modeling outbreak mitigation effectiveness compliance"
11,coronavirus hospital rationing,what are the guidelines for triaging patients infected with coronavirus?,"Seeking information on any guidelines for prioritizing COVID-19 patients infected with coronavirus based on demographics, clinical signs, serology and other tests.","COVID-19 triage guidelines resource allocation ventilator shortage clinical prioritization severity scoring hospitalization ICU","COVID-19 triage resource allocation severity index critical care prioritization ethical frameworks rationing"
12,coronavirus quarantine,what are best practices in hospitals and at home in maintaining quarantine?,"Seeking information on best practices for activities and duration of quarantine for those exposed and/ infected to COVID-19 virus.","COVID-19 quarantine isolation best practices exposure management infection control guidelines hospital home","COVID-19 quarantine protocols isolation guidelines duration infection control hospital community"
13,how does coronavirus spread,what are the transmission routes of coronavirus?,"Looking for information on all possible ways to contract COVID-19 from people, animals and objects","SARS-CoV-2 transmission routes respiratory droplets aerosols fomite contact person-to-person zoonotic spread airborne","SARS-CoV-2 transmission droplet aerosol fomite contact pathophysiology R0 airborne"
14,coronavirus super spreaders,what evidence is there related to COVID-19 super spreaders,"seeking range of information related to the number and proportion of super spreaders, their patterns of behavior that lead to spread, and potential prevention strategies targeted specifically toward super spreaders","COVID-19 super-spreaders high transmission events cluster outbreaks epidemiology behavior contact tracing prevention strategies","COVID-19 super-spreaders cluster events transmission dynamics targeted interventions epidemiological patterns"
15,coronavirus outside body,how long can the coronavirus live outside the body,"seeking range of information on the SARS-CoV-2's virus's survival in different environments (surfaces, liquids, etc.) outside the human body while still being viable for transmission to another human","SARS-CoV-2 viability surfaces environment stability survival external conditions contamination viral persistence","SARS-CoV-2 surface stability environmental factors viral persistence survival contamination infectivity"
16,how long does coronavirus survive on surfaces,how long does coronavirus remain stable  on surfaces?,"Studies of time SARS-CoV-2 remains stable after being deposited from an infected person on everyday surfaces in a household or hospital setting, such as through coughing or touching objects.","SARS-CoV-2 surface stability fomite transmission contamination viability duration environment materials","SARS-CoV-2 surface contamination stability viral persistence time factors material differences"
17,coronavirus clinical trials,are there any clinical trials available for the coronavirus,"seeking specific COVID-19 clinical trials ranging from trials in recruitment to completed trials with results","COVID-19 clinical trials interventions treatments randomized controlled recruitment drug efficacy vaccine outcomes","COVID-19 clinical trials RCT ongoing completed interventions outcomes vaccine therapy"
18,masks prevent coronavirus,what are the best masks for preventing infection by Covid-19?,"What types of masks should or should not be used to prevent infection by Covid-19?","COVID-19 masks respiratory protection surgical masks N95 filtration aerosol spread droplet prevention","COVID-19 masks N95 filtration aerosol containment infection prevention barrier efficacy"
19,what alcohol sanitizer kills coronavirus,what type of hand sanitizer is needed to destroy Covid-19?,"Studies assessing chemicals and their concentrations needed to destroy the Covid-19 virus.","SARS-CoV-2 hand sanitizer alcohol concentration ethanol isopropanol disinfectant viral inactivation hygiene virucidal potency","SARS-CoV-2 sanitizer alcohol concentration efficacy ethanol isopropanol virucidal potency recommended guidelines"
20,coronavirus and ACE inhibitors,are patients taking Angiotensin-converting enzyme inhibitors (ACE) at increased risk for COVID-19?,"Looking for information on interactions between  coronavirus and  angiotensin converting enzyme 2 (ACE2) receptors, risk for patients taking these medications, and recommendations for these patients.","COVID-19 ACE inhibitors ACE2 receptors hypertension risk renin-angiotensin system ARBs cardiovascular RAAS","COVID-19 ACE2 inhibitors risk RAAS blockade hypertension cardiovascular outcomes recommendations"
21,coronavirus mortality,what are the mortality rates overall and in specific populations,"Seeking  information on COVID-19 fatality rates in different countries and in different population groups based on gender, blood types, or other factors","COVID-19 mortality fatality rate demographic differences comorbidity severity CFR global variation population groups","COVID-19 mortality rates demographics comorbidity case fatality risk disparities subpopulations"
22,coronavirus heart impacts,are cardiac complications likely in patients with COVID-19?,"Seeking information on the types, frequency and mechanisms of cardiac complications caused by coronavirus.","COVID-19 cardiac complications myocarditis arrhythmia myocardial injury troponin cardiomyopathy acute coronary disease","COVID-19 cardiac complications myocarditis arrhythmia myocardial injury pathophysiology risk severity"
23,coronavirus hypertension,what kinds of complications related to COVID-19 are associated with hypertension?,"seeking specific outcomes that hypertensive  (any type) patients are more/less likely to face if infected with the virus","COVID-19 hypertension risk complications severe outcomes blood pressure comorbidity pathophysiology severity","COVID-19 hypertension comorbidity severity complications management risk assessment outcomes"
24,coronavirus diabetes,what kinds of complications related to COVID-19 are associated with diabetes,"seeking specific outcomes that diabetic (any type) patients are more/less likely to face if infected with the virus","COVID-19 diabetes metabolic comorbidity hyperglycemia insulin resistance severe outcomes pathophysiology complications","COVID-19 diabetes comorbidity glycemic control risk severity complications management outcomes"
25,coronavirus biomarkers,which biomarkers predict the severe clinical course of 2019-nCOV infection?,"Looking for information on biomarkers that predict disease outcomes in people infected with coronavirus, specifically those that predict severe and fatal outcomes.","COVID-19 biomarkers prognosis CRP D-dimer ferritin IL-6 troponin severity prediction inflammatory markers","COVID-19 prognostic biomarkers CRP ferritin IL-6 D-dimer severity risk outcome"
26,coronavirus early symptoms,what are the initial symptoms of Covid-19?,"Studies of patients and the first clinical manifestations they develop upon active infection?","COVID-19 early symptoms fever cough fatigue anosmia dyspnea onset mild stage initial presentation","COVID-19 initial symptoms fever cough anosmia onset progression clinical presentation"
27,coronavirus asymptomatic,what is known about those infected with Covid-19 but are asymptomatic?,"Studies of people who are known to be infected with Covid-19 but show no symptoms?","COVID-19 asymptomatic carriers silent infection transmission testing screening prevalence subclinical detection","COVID-19 asymptomatic infection subclinical transmission detection prevalence public health implications"
28,coronavirus hydroxychloroquine,what evidence is there for the value of hydroxychloroquine in treating Covid-19?,"Basic science or clinical studies assessing the benefit and harms of treating Covid-19 with hydroxychloroquine.","COVID-19 hydroxychloroquine treatment antimalarial therapy efficacy safety clinical trials adverse events controversy","COVID-19 hydroxychloroquine clinical evidence antiviral activity benefit risk controversies recommendation"
29,coronavirus drug repurposing,which SARS-CoV-2 proteins-human proteins interactions indicate potential for drug targets. Are there approved drugs that can be repurposed based on this information?,"Seeking information about protein-protein interactions for any of the SARS-CoV-2  structural proteins that represent a promising therapeutic target,  and the drug  molecules that may inhibit the virus and the host cell receptors at entry step.","SARS-CoV-2 drug repurposing protein-protein interactions host-virus targets antiviral agents FDA-approved therapies screening","SARS-CoV-2 drug repurposing host-virus binding structural proteins therapeutic screening candidate compounds"
30,coronavirus remdesivir,is remdesivir an effective treatment for COVID-19,"seeking specific information on clinical outcomes in COVID-19 patients treated with remdesivir","COVID-19 remdesivir antiviral efficacy polymerase inhibitor clinical outcomes safety FDA approval RCT results","COVID-19 remdesivir clinical trial efficacy viral load reduction adverse effects treatment guidelines"
31,difference between coronavirus and flu,How does the coronavirus differ from seasonal flu?,"Includes studies ranging from those focusing on genomic differences to global public health impacts, but must draw direct comparisons between COVID-19 and seasonal influenza.","SARS-CoV-2 influenza comparison genomic differences epidemiology transmission severity immune response hospitalization","SARS-CoV-2 influenza direct comparison genomic structure transmissibility severity mortality public health"
32,coronavirus subtypes,"Does SARS-CoV-2 have any subtypes, and if so what are they?","Papers that discuss subtypes of the virus, from named subtypes to speculative subtypes based on genomic or geographic clustering.","SARS-CoV-2 subtypes variants lineages genetic diversity clades phylogenetics spike mutations classification","SARS-CoV-2 subtypes genomic variants clade classification phylogenetic clustering strain differences emerging lineages"
33,coronavirus vaccine candidates,What vaccine candidates are being tested for Covid-19?,"Seeking studies that discuss possible, but specific, COVID-19 vaccines. Includes articles from those describing the mechanisms of action of specific proposed vaccines to actual clinical trials, but excluding articles that do not name a specific vaccine candidate.","COVID-19 vaccine candidates mRNA viral vector protein subunit inactivated clinical trials immunogenicity efficacy","COVID-19 vaccine candidates clinical development immunogenicity efficacy preclinical trials neutralizing antibodies"
34,coronavirus recovery,What are the longer-term complications of those who recover from COVID-19?,"Seeking information on the health outcomes for those that recover from the virus. Excludes studies only focusing on adverse effects related to a particular COVID-19 drug.","COVID-19 recovery long-term effects complications post-infection sequelae rehabilitation persistent symptoms follow-up","COVID-19 recovery outcomes long-term sequelae persistent symptoms post-acute follow-up"
35,coronavirus public datasets,What new public datasets are available related to COVID-19?,"Seeking articles that specifically release new data related to SARS-CoV-2 or COVID-19, including genomic data, patient data, public health data, etc. Articles that reference previously existing datasets are not relevant.","COVID-19 public datasets genomic data epidemiological patient data open-source repositories GISAID new resources","COVID-19 new datasets genomic epidemiological patient data publicly available updated resources"
36,SARS-CoV-2 spike structure,What is the protein structure of the SARS-CoV-2 spike?,"Looking for studies of the structure of the spike protein on the virus using any methods, such as cryo-EM or crystallography","SARS-CoV-2 spike protein structure cryo-EM receptor-binding domain S1 S2 conformational changes glycoprotein analysis","SARS-CoV-2 spike structure RBD cryo-EM domain architecture conformational dynamics receptor binding"
37,SARS-CoV-2 phylogenetic analysis,What is the result of phylogenetic analysis of SARS-CoV-2 genome sequence?,"Looking for a range of studies which provide the results of phylogenetic network analysis on the SARS-CoV-2 genome","SARS-CoV-2 phylogenetics genomic evolution molecular epidemiology lineage tracing global strains phylogenetic network analysis","SARS-CoV-2 phylogenetic analysis lineage mapping evolutionary history genetic clustering molecular epidemiology"
38,COVID inflammatory response,What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases?,"Looking for a range of studies which describes the inflammatory response cells and pathogenesis during the Coronavirus Disease 2019 (COVID-19) outbreak, including the mechanism of anti-inflammatory drugs, corticosteroids, and vitamin supplements","COVID-19 inflammatory response pathogenesis immune cells cytokines IL-6 immunomodulation corticosteroids vitamin supplements","COVID-19 inflammation pathogenesis cytokine release immune dysregulation therapy mechanisms immunomodulators"
39,COVID-19 cytokine storm,What is the mechanism of cytokine storm syndrome on the COVID-19?,"Looking for studies that describes mechanism of development of cytokine storm syndrome among COVID-19 cases and the range of drugs used for the therapy of cytokine storm","COVID-19 cytokine storm hyperinflammation IL-6 IL-1 TNF pathophysiology immunotherapy tocilizumab","COVID-19 cytokine storm mechanism immunopathology IL-6 blockade anti-inflammatory therapy hyperinflammation"
40,coronavirus mutations,What are the observed mutations in the SARS-CoV-2 genome and how often do the mutations occur?,"Looking for studies that describes the emergence of genomic diversity of the coronavirus due to recurrent mutations which explore the potential genomic site of the mutation, mechanisms and its potential or observed clinical implications in the pathogenicity of the virus","SARS-CoV-2 mutations genomic diversity recurring variants spike changes evolutionary rate pathogenic implications","SARS-CoV-2 mutations genomic sites recurrent variants pathogenic impact clinical significance evolution"
41,COVID-19 in African-Americans,What are the impacts of COVID-19 among African-Americans that differ from the rest of the U.S. population?,"Looking for studies that analyze burden of illness and death among the African-American/black racial/ethnic group. This includes potential reasons for transmission, morbidity, and mortality. This may include discussion of other minority groups, but all studies should contain specific information on the health disparities faced by African-Americans in this pandemic.","COVID-19 African-Americans health disparities social determinants mortality morbidity racial inequities disproportionate burden","COVID-19 African-Americans disproportionate impact comorbidity structural racism outcomes analysis minority groups"
42,Vitamin D and COVID-19,Does Vitamin D impact COVID-19 prevention and treatment?,"This includes studies describing possible role of Vitamin D in prevention of COVID-19, suppression of cytokine storm, clinical outcomes, and associations between Vitamin D status and COVID-19 mortality.","COVID-19 vitamin D deficiency supplementation immune modulation cytokine storm mortality association prevention therapy","COVID-19 vitamin D immunomodulatory effect deficiency supplementation outcomes risk mortality association"
43,violence during pandemic,"How has the COVID-19 pandemic impacted violence in society, including violent crimes?","Looking for analyses and data on how the pandemic is impacting rates of violence, including domestic/family violence related to quarantine.","COVID-19 pandemic violence domestic abuse quarantine stress social isolation mental health interpersonal conflict","COVID-19 violence domestic abuse quarantine incidence risk factors data psychosocial consequences"
44,impact of masks on coronavirus transmission,How much impact do masks have on preventing the spread of the COVID-19?,"Looking for studies of how masks slow SARS-CoV-2 transmission, including impact on R0. Studies can include both lab and population studies.","COVID-19 masks transmission reduction R0 face coverings community protection population studies prevention measure","COVID-19 mask efficacy transmission control population-level impact infection prevention R0 reduction"
45,coronavirus mental health impact,How has the COVID-19 pandemic impacted mental health?,"Includes increasing/decreasing rates of depression, anxiety, panic disorder, and other psychiatric and mental health conditions.","COVID-19 mental health depression anxiety stress PTSD lockdown psychological burden population well-being","COVID-19 mental health depression anxiety psychosocial effects coping strategies pandemic impact"
46,dexamethasone coronavirus,what evidence is there for dexamethasone as a treatment for COVID-19?,"Looking for studies on the impact of dexamethasone treatment in COVID-19 patients, including health benefits as well as adverse effects. This also includes specific populations that are benefitted/harmed by dexamethasone.","COVID-19 dexamethasone corticosteroid therapy anti-inflammatory effects mortality reduction clinical trials population benefits adverse outcomes","COVID-19 dexamethasone treatment outcomes anti-inflammatory benefits adverse reactions randomized trials"
47,COVID-19 outcomes in children,what are the health outcomes for children who contract COVID-19?,"Looking for studies on health outcomes in children related to COVID-19. This includes studies attempting to explain the underlying biological mechanisms for why children differ from adults in response to infection.","COVID-19 children pediatric outcomes mild cases MIS-C pathophysiology transmission immunity hospitalization severity","COVID-19 pediatric outcomes MIS-C severity risk factors immune response differences child health"
48,school reopening coronavirus,what are the benefits and risks of re-opening schools in the midst of the COVID-19 pandemic?,"With the possibility of schools re-opening while the COVID-19 pandemic is still ongoing, this topic is looking for evidence or projections on what the potential implications of this are in terms of COVID-19 cases, hospitalizations, or deaths, as well as other benefits or harms to re-opening schools. This includes both the impact on students, teachers, families, and the wider community.","COVID-19 school reopening transmission risk child infection educational impact modeling public policy community implications","COVID-19 school reopening risk-benefit analysis transmission modeling community impact public health guidance"
49,post-infection COVID-19 immunity,"do individuals who recover from COVID-19 show sufficient immune response, including antibody levels and T-cell mediated immunity, to prevent re-infection?","There is concern about re-infection for COVID-19, so this topic is looking for studies suggesting post-infection immunity, including post-infection antibody levels (over time) and evidence for individuals who have been infected more than once.","COVID-19 post-infection immunity antibodies T-cell response reinfection protection durability convalescence immune memory","COVID-19 post-infection immunity antibody titers T-cell memory reinfection evidence immune durability"
50,mRNA vaccine coronavirus,what is known about an mRNA vaccine for the SARS-CoV-2 virus?,"Looking for studies specifically focusing on mRNA vaccines for COVID-19, including how mRNA vaccines work, why they are promising, and any results from actual clinical studies.","COVID-19 mRNA vaccine messenger RNA immunization spike protein encapsulation clinical trials immune response efficacy","COVID-19 mRNA vaccine platform immunogenicity phase trials efficacy lipid nanoparticle technology"
